Novapio 15 mg tablete

Name	Novapio 15 mg tablete
Marketing Authorisation Number	HR-H-574691629
Active Substance	pioglitazonklorid
Composition	jedna tableta sadrži 15 mg pioglitazona (u obliku klorida)
Pharmaceutical Form	tableta
Manufacturer	Laboratori Fundacio Dau, Barcelona, Španjolska
Marketing Authorisation Holder	Novatin Limited, 5a Bokka Tac-Carcara, Limiti Ta'L-Mgarr, Malta
Marketing Authorisation Date	20.09.2023
MA Period of Validity	unlimited
Classification Number	UP/I-530-09/23-02/130
Registration Number	381-12-01/171-23-05
Prescription	Medicinal product subject to medical prescription
Type of prescription	Medicinal product on medical prescription for renewable delivery
Distribution	Supply through pharmacies (community)
Advertising to general public	not allowed
ATC Code	A10BG03
Marketing status	Marketed
Shortage status	No shortage
SmPC	download
PL	download
Public Assessment Report	download
Summary of risk management plan	download

Packaging description	MA Number for Packaging	Marketing status	Shortage status
14 tableta u blisteru, u kutiji	HR-H-574691629-01	Never marketed	-
28 tableta u blisteru, u kutiji	HR-H-574691629-02	Never marketed	-
30 tableta u blisteru, u kutiji	HR-H-574691629-03	Marketed	No shortage
50 tableta u blisteru, u kutiji	HR-H-574691629-04	Never marketed	-
56 tableta u blisteru, u kutiji	HR-H-574691629-05	Never marketed	-
84 tablete u blisteru, u kutiji	HR-H-574691629-06	Never marketed	-
90 tableta u blisteru, u kutiji	HR-H-574691629-07	Never marketed	-
98 tableta u blisteru, u kutiji	HR-H-574691629-08	Never marketed	-
112 tableta u blisteru, u kutiji	HR-H-574691629-09	Never marketed	-
196 tableta u blisteru, u kutiji	HR-H-574691629-10	Never marketed	-
45 tableta u blisteru, u kutiji	HR-H-574691629-11	-	-

Medicinal Products